cancer

Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that.

Biotech & Health /

Artificial intelligence is a big trend in cancer care, and it’s mostly focused on detecting cancer at the earliest possible stage. That makes a lot of sense, given that cancer is less deadly the earlier it’s detected. But fewer are asking another fundamental question: if someone does have cancer, is an aggressive treatment like chemotherapy […]

Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that. Read More »

Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment

Biotech & Health /

Artificial intelligence is a big trend in cancer care, and it’s mostly focused on detecting cancer at the earliest possible stage. That makes a lot of sense, given that cancer is less deadly the earlier it’s detected. But fewer are asking another fundamental question: If someone does have cancer, is an aggressive treatment like chemotherapy

Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment Read More »

Reid Hoffman’s Manas AI raises $24.6M, a fraction of other AI drug discovery startups

Fundraising /

LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an AI-powered drug discovery startup, Manas AI. The company, which will initially focus on breast cancer, prostate cancer, and lymphoma, has raised $24.6 million in seed funding from Hoffman, General Catalyst, and Greylock. Manas

Reid Hoffman’s Manas AI raises $24.6M, a fraction of other AI drug discovery startups Read More »

Study claims AI could boost detection of breast cancer by 21%

Biotech & Health /

A U.S. breast-screening program claims to demonstrate the potential benefits of using artificial intelligence (AI) in mammography screening, with women who paid for AI-enhanced scans 21% more likely to have cancer detected. DeepHealth, an AI firm owned by radiology giant RadNet, presented its findings at the annual meeting of the Radiological Society of North America

Study claims AI could boost detection of breast cancer by 21% Read More »

Luminate’s hair-saving chemo helmet nears release, as new funding goes toward home cancer care

Biotech & Health /

Luminate’s wearable device for hair retention during chemotherapy treatment is getting the testing it needs for commercial release, but the startup is already looking ahead to its next goal: powering at-home cancer care. A new $15 million funding round should help it make a start on it. The startup is one of the most unusual,

Luminate’s hair-saving chemo helmet nears release, as new funding goes toward home cancer care Read More »